1. Home
  2. CRL vs CFR Comparison

CRL vs CFR Comparison

Compare CRL & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$161.25

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Logo Cullen/Frost Bankers Inc.

CFR

Cullen/Frost Bankers Inc.

HOLD

Current Price

$139.46

Market Cap

8.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRL
CFR
Founded
1947
1868
Country
United States
United States
Employees
N/A
6008
Industry
Biotechnology: Commercial Physical & Biological Resarch
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
8.8B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
CRL
CFR
Price
$161.25
$139.46
Analyst Decision
Buy
Hold
Analyst Count
12
13
Target Price
$198.27
$142.31
AVG Volume (30 Days)
790.6K
496.4K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
2.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,857,601,000.00
N/A
Revenue This Year
N/A
$9.72
Revenue Next Year
$3.04
$4.70
P/E Ratio
N/A
$14.55
Revenue Growth
10.48
N/A
52 Week Low
$132.58
$119.00
52 Week High
$228.88
$148.97

Technical Indicators

Market Signals
Indicator
CRL
CFR
Relative Strength Index (RSI) 45.38 51.17
Support Level $147.22 $133.95
Resistance Level $166.62 $146.09
Average True Range (ATR) 8.97 2.48
MACD -1.18 0.12
Stochastic Oscillator 31.12 64.55

Price Performance

Historical Comparison
CRL
CFR

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About CFR Cullen/Frost Bankers Inc.

Cullen/Frost is a regional US bank with around $53 billion in assets (as of December 2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.

Share on Social Networks: